SCHEMBL17591503

SCHEMBL17591503

Cc1ccc(C)c(/N=C\C=N/N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.44
ALDH1A1 P00352 7/20 0.39
TDP1 Q9NUW8 3/20 0.39
MAPT P10636 7/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
KDM4E B2RXH2 5/20 0.38
HTT P42858 5/20 0.38
LMNA P02545 4/20 0.38
CYP3A4 P08684 2/20 0.38
ADRA2A P08913 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
GAA P10253 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PKM P14618 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17591519 0.81 ALDH1A1 (0.46) ALDH1A1MAPTKDM4ECYP3A4GAA
SCHEMBL20221393 0.78 DHODH (0.45) DHODHALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL7093738 0.78 DHODH (0.45) DHODHALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL20663205 0.78 DHODH (0.47) DHODHALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL17591502 0.76 LMNA (0.50) ALDH1A1TDP1MAPTSMN1; SMN2KDM4E
SCHEMBL20726017 0.75 DHODH (0.49) DHODHALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL6245212 0.73 CYP3A4 (0.64) ALDH1A1TDP1MAPTSMN1; SMN2KDM4E
SCHEMBL11020065 0.71 TDP1 (0.44) DHODHALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL11022109 0.71 TDP1 (0.44) DHODHALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL22991960 0.71 MAPT (0.49) DHODHALDH1A1TDP1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776430-B1 2- (1,2,3-TRIAZOL-2-YL) BENZAMIDE AND 3-(1,2,3-TRIAZOL-2-YL) PICOLINAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-03-16 EP disclosed